Praxis Precision Medicines PRAX Stock
Praxis Precision Medicines Price Chart
Praxis Precision Medicines PRAX Financial and Trading Overview
| Praxis Precision Medicines stock price | 55.16 USD |
| Previous Close | 0.85 USD |
| Open | 0.88 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 1000 |
| Day's Range | 0.86 - 0.94 USD |
| 52 Week Range | 0.79 - 5.25 USD |
| Volume | 1.1M USD |
| Avg. Volume | 834.82K USD |
| Market Cap | 56.2M USD |
| Beta (5Y Monthly) | 3.035516 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -18.69 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.1 USD |
PRAX Valuation Measures
| Enterprise Value | -29775902 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.41324198 |
| PEG Ratio (5 yr expected) | 0.03 |
| Price/Sales (ttm) | 82.28649 |
| Price/Book (mrq) | 0.8138489 |
| Enterprise Value/Revenue | -43.596 |
| Enterprise Value/EBITDA | 0.162 |
Trading Information
Praxis Precision Medicines Stock Price History
| Beta (5Y Monthly) | 3.035516 |
| 52-Week Change | -56.49% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.25 USD |
| 52 Week Low | 0.79 USD |
| 50-Day Moving Average | 1.01 USD |
| 200-Day Moving Average | 2.11 USD |
PRAX Share Statistics
| Avg. Volume (3 month) | 834.82K USD |
| Avg. Daily Volume (10-Days) | 1.08M USD |
| Shares Outstanding | 62.1M |
| Float | 47.6M |
| Short Ratio | 6.32 |
| % Held by Insiders | 0.66% |
| % Held by Institutions | 111.61% |
| Shares Short | 4.41M |
| Short % of Float | 7.14% |
| Short % of Shares Outstanding | 7.09% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -26973.35% |
| Gross Margin | 4074.81% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -68.15% |
| Return on Equity (ttm) | -143.072% |
Income Statement
| Revenue (ttm) | 683K USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -183796000 USD |
| Net Income Avi to Common (ttm) | -182767008 USD |
| Diluted EPS (ttm) | -3.41 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 85.82M USD |
| Total Cash Per Share (mrq) | 1.38 USD |
| Total Debt (mrq) | 3.26M USD |
| Total Debt/Equity (mrq) | 5.06 USD |
| Current Ratio (mrq) | 3.156 |
| Book Value Per Share (mrq) | 1.112 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -163780000 USD |
| Levered Free Cash Flow (ttm) | -98505504 USD |
Profile of Praxis Precision Medicines
| Country | United States |
| State | MA |
| City | Boston |
| Address | 99 High Street |
| ZIP | 02110 |
| Phone | 617 300 8460 |
| Website | https://praxismedicines.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 109 |
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase IIb clinical trial for the treatment of essential tremor, as well as in Phase II clinical trial to treat Parkinson's disease; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc.; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc.; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.
Q&A For Praxis Precision Medicines Stock
What is a current PRAX stock price?
Praxis Precision Medicines PRAX stock price today per share is 55.16 USD.
How to purchase Praxis Precision Medicines stock?
You can buy PRAX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Praxis Precision Medicines?
The stock symbol or ticker of Praxis Precision Medicines is PRAX.
Which industry does the Praxis Precision Medicines company belong to?
The Praxis Precision Medicines industry is Biotechnology.
How many shares does Praxis Precision Medicines have in circulation?
The max supply of Praxis Precision Medicines shares is 17.09M.
What is Praxis Precision Medicines Price to Earnings Ratio (PE Ratio)?
Praxis Precision Medicines PE Ratio is now.
What was Praxis Precision Medicines earnings per share over the trailing 12 months (TTM)?
Praxis Precision Medicines EPS is -18.69 USD over the trailing 12 months.
Which sector does the Praxis Precision Medicines company belong to?
The Praxis Precision Medicines sector is Healthcare.
Praxis Precision Medicines PRAX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}